Grown Alchemist exits L'Occitane portfolio, eyes international growth
Grown Alchemist has a new owner. L'Occitane has divested the Australian beauty brand it acquired in 2022 and sold a majority stake to André Hoffmann, the group's former vice-chairman, former chief executive and current board member. Meanwhile, Grown Alchemist CEO Anna Teal bought out minority shareholders. The total price of this transaction is 28 million euros, and the brand will be headquartered in London, England.
The new owners hope to accelerate the brand's growth through increased business agility and large-scale partnerships and events across lifestyle, music and retail, particularly in key markets such as North America and China.
"Since acquiring a majority controlling stake in 2022, Groupe L’Occitane has been an incredible partner and supporter of the business, allowing us to build a strong foundation for growth, a great team, product enhancement investments and new market entry,” said Teal, CEO of Grown Alchemist.
"That being said, we view this acquisition of Grown Alchemist as an opportunity to accelerate brand growth as we gain additional strategic flexibility and autonomy outside of the listed group. We thank the Group for its openness and support for this transformation of our growth strategy, which is in line with both parties. "
Founded in Australia in 2008, Grown Alchemist is sold in more than 40 countries at retail chains such as Sephora and Credo Beauty, as well as five-star hotels and spas.
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L'Occitane billionaire owner Reinold Geiger mulls taking company private in potential $7 billion deal
-
Sales of L'Occitane increased 18.8% year-on-year in its first fiscal quarter
-
Singapore Orders Nestlé Formula Recall as Infant Safety Comes Under the Spotlight
-
Cheap Sugar, Costly Lives: WHO Pushes Governments Toward a New Era of Health Taxes
-
U.S. EPA Targets Perchlorate: A New Safety Line Drawn in Drinking Water Standards
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Death Toll from Fire at China-Russia Amur Polyolefins Project Rises to 15 as Construction Continues
-
He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face
-
Australia Launches Anti-Circumvention Trade Probe into China’s 2,4-D Supply Chain
-
Global Chemical Exports Are Freezing in 2026
Recommend Reading
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
-
South Korea to Impose Anti-Dumping Duties on Caustic Soda: Chinese Mainland Firms Face Up to 22.21%, Taiwan Region 38.89%
-
Wanhua Shuts 1.1 Million-Tonne Yantai MDI Unit for 45-Day Maintenance
-
“Changing the Captain at Sea”: Hempel’s CEO Departs to Run a Ferry Giant—This Isn’t a Resignation Notice, It’s an Industry Stress Map
-
European Chemical Firms Face Pressure on First-Quarter Earnings as the War Shock Continues to Spread
-
Business Society’s PVC Market Outlook on August 26, 2026: Weak and Volatile
-
In November, the caustic soda price generally declined in China
-
This Week, PET Bottle Chip Spot and Futures Prices Move Downward in Tandem in China
-
This Week's Styrene Market Fluctuates and Declines (6.8-6.12) in China
-
Business Society’s Market Outlook for Acrylic Acid on September 2, 2026: Fluctuating Trend
- Hot Searches
- adipic acid price
- salmeterol fluticasone
- sulfuric acid price
- buy sr17018
- scopolamine powder for sale
- tirzepatide research peptide for sale
- hexylene glycol sds
- good research chemical sites
- retatrutide peptide buy usa price
- best place to buy retatrutide peptides online
- best research chemical website
- enterobacter cloacae